Victoria Rogan 6/6/25 Victoria Rogan 6/6/25

New Local Clinical Trial Recruiting Now!

Victoria Rogan 12/5/25 Victoria Rogan 12/5/25

omav Early Access Program Not Impacted by PBAC Decision

Victoria Rogan 24/4/25 Victoria Rogan 24/4/25

Victoria Rogan 19/2/25 Victoria Rogan 19/2/25

Victoria Rogan 4/2/25 Victoria Rogan 4/2/25

Victoria Rogan 17/1/25 Victoria Rogan 17/1/25

Victoria Rogan 4/12/24 Victoria Rogan 4/12/24

Victoria Rogan 28/11/24 Victoria Rogan 28/11/24

Victoria Rogan 16/9/24 Victoria Rogan 16/9/24

Victoria Rogan 5/9/24 Victoria Rogan 5/9/24

Victoria Rogan 11/7/24 Victoria Rogan 11/7/24

Victoria Rogan 11/3/24 Victoria Rogan 11/3/24

Victoria Rogan 15/2/24 Victoria Rogan 15/2/24

Victoria Rogan 19/9/23 Victoria Rogan 19/9/23

Victoria Rogan 2/8/23 Victoria Rogan 2/8/23

Victoria Rogan 23/6/23 Victoria Rogan 23/6/23

fara co-funded four new Research Programs & extended three other grants into their second years in 2022/2023

Victoria Rogan 12/3/19 Victoria Rogan 12/3/19

Omaveloxolone granted US Food & Drug administration regulatory approval

Victoria Rogan 12/3/19 Victoria Rogan 12/3/19

New fundraising partnership with Pan American Seed